European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact

ESU introduces new mHSPC e-course

The newly-published e-course covers the definition, classification, and heterogeneity of metastatic hormone-sensitive prostate cancer (mHSPC).

Thu, 4 Jun 2020
M HSPCE CourseCME CreditsADTEAU Education Office ESU

Today marks the launch of the e-course “Metastatic Hormone-Sensitive Prostate Cancer” the 3rd in the series “Advanced Prostate Cancer”. The European School of Urology (ESU) offers an array of popular digital activities such as these to bolster the knowledge of young and experienced urologists alike.

The newly-published e-course covers the definition, classification, and heterogeneity of metastatic hormone-sensitive prostate cancer (mHSPC). Through this e-course, you will know more about the diverse features and outcomes of mHSPC in various patient populations with a particular focus on updated treatment guidelines.

The e-course is comprised of 4 chapters:

  • Chapter 1: Definition and classification
  • Chapter 2: Clinical evaluation
  • Chapter 3: Treatment
  • Chapter 4: Follow-up and surveillance strategies

The e-course is recognised by the European Accreditation Council for Continuing Medical Education (EACCME) with 2 European CME credits (ECMEC®) and will take approximately 120 minutes to complete.

Test your knowledge, take the e-course now, and receive your CME credits and a downloadable certificate.

This-course is supported by an independent educational grant from Janssen Pharmaceutical Companies of Johnson & Johnson.

About the series

Developed under the guidance and expertise of EAU PCa Guidelines Panel Chair Prof. Dr. Nicolas Mottet (FR), the e-course series “Advanced Prostate Cancer” provides developments on androgen deprivation therapy (ADT); hormone-sensitive metastatic (mPCa) and non-metastatic prostate cancer (nmPCa); metastatic (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC).

The series consists of 5 courses that deliver information on diagnostic tools, prognosis and predictive factors, patient stratification, and treatment options for patients with mPCa, nmPCa, mCRPC or nmCRPC. The courses are designed to evaluate a participant’s ability to apply newfound knowledge in devising care pathways for patients.

E-course opportunities

Interested in taking the first e-course of the series, “Basis of ADT”? Access the e-course now via this link. This e-course will take approximately 90 minutes to finish. You will receive 1 CME credit and a downloadable certificate upon completion.

How does your knowledge fare on other urological topics such as urolithiasis, men’s health, chronic pelvic pain, renal cancer, and more? Assess your know-how and accumulate CME credits at the same time by completing other ESU e-courses. Explore the e-course overview now.

Enlarge image

Share this article

Suggested for you

See all
About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer